Maximum quantity allowed is 999
请选择数量
CAS RN: 86227-47-6 | 產品號碼: E0853
Ethyl all cis-5,8,11,14,17-Eicosapentaenoate (stabilized with Tocopherols)
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品規格
Appearance | Colorless to Light orange to Yellow clear liquid |
Purity(GC) | min. 65.0 % |
性質
flp | 103 °C |
比重 | 0.91 |
折射率 | 1.49 |
GHS
相關法規
運輸資料
HS編碼* | 2916.19-000 |
Application
EPA Ethyl Ester: An Unsaturated ω-3 Fatty Acid Ester
EPA ethyl ester is an ester of EPA [E0441] which belongs to the class of unsaturated ω-3 (n-3) fatty acids and is rich in fish oil. EPA ethyl ester is approved to reduce triglyceride (TG) levels in blood since ω-3 fatty acids reduce TG levels. Recently, it has been reported that EPA ethyl ester have efficacy in depression, Huntington disease (HD) and et al., but these mechanism of actions are not fully understood. (The product is for research purpose only.)
References
- Mechanism of the lipid-lowering effect on ethyl all-cis 5,8,11,14,17-icosapentaenoate
- Ethyl all-cis-5,8,11,14,17-eicosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein
- Icosapent ethyl for the treatment of hypertriglyceridemia (a review)
- Effects of dietary n-3 or n-6 fatty acids on interleukin-1β-induced anxiety, stress, and inflammatory responses in rats
- Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression (a review)
- Ethyl-EPA in Huntington disease-Potentially relevant mechanism of action (a review)
考研文獻
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。